Guaifenesin Tablet, Extended Release
Product Images NDC 69848-018

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Guaifenesin (NDC 69848-018). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

14ct (Ggf 14ct)

The packaging label for Guaifenesin Extended-Release Tablets 1200 mg by Granules USA, Inc. This OTC product is an expectorant available as extended-release, bi-layer tablets with 14 tablets per package. The label highlights maximum strength, 12-hour relief, and benefits like relieving chest congestion and thinning mucus. The image shows a blue carton with usage warnings, drug facts, and tamper-evident information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.